MC38-hFOLR1

PDFを取得

Strain Information

表現型データ

image.png

Fig1. hFOLR1 expression in in vitro cultured cells of MC38-hFOLR1.

image.png

Fig2. In vivo validation of MC38-hFOLR1 in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-hFOLR1 subcutaneously at 1×106 cells/mouse inoculum for tumor development.Note: MC38-hFOLR1 (clone #8) is recommended for in vivo studies.

image.png

Fig3. hFOLR1 expression in tumors after in vivo growth of MC38-hFOLR1 in wild type C57BL/6 mice. The tumors were collected at day 22 post tumor cell inoculation.

image.png

Fig4. hFOLR1 expression in tumors after in vivo growth of MC38-hFOLR1 in wild type C57BL/6 mice. The tumors were collected at day 26 post tumor cell inoculation.


関連の系統

あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

詳細